Login
$CCG
$7.51 -$0.34 (4.33%) Close

Consolidated Balance Sheets

In millions of CNY, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Short-term investments
Accounts receivable, net
Prepayments and other current assets
Total current assets
Non-current assets:
Restricted cash
Property, equipment and leasehold improvement, net
Intangible assets, net
Right-of-use assets
Goodwill
Other non-current assets
Total non-current assets
TOTAL ASSETS
LIABILITIES
Current liabilities
Accounts payable
Short term borrowings
Contract liabilities
Salary and welfare benefits payable
Tax payable
Amounts due to related party
Accrued expenses and other current liabilities
Short-term lease liabilities
Warrant
Total current liabilities
Non-current liabilities
Deferred tax liabilities
Long-term lease liabilities
Long-term borrowings
Amounts due to related party
Deferred revenue
Warrant
Total non-current liabilities
TOTAL LIABILITIES
SHAREHOLDERS’ EQUITY:
Ordinary shares (US$ 0.00001 par value, 5,000,000,000 and 5,000,000,000 shares (4,000,000,000 Class A ordinary shares and 1,000,000,000 Class B ordinary shares) authorized as of December 31, 2024 and 2025, respectively; 80,321,873 and 83,020,061 shares (64,423,557 Class A ordinary shares and 18,596,504 Class B ordinary shares) issued and outstanding as of December 31, 2024 and 2025, respectively)
Treasury stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income/(loss)
TOTAL SHAREHOLDERS’ EQUITY:
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support